EGFR and neoplasm: Unlike EGFR hotspot testing, a complete exonic analysis of the EGFR gene by the NGS of tumor-derived materials (ctDNA or tissue) can facilitate a thorough assessment of EGFR mutations to guide patients toward the most appropriate treatment.